FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984830708> ?p ?o ?g. }

• W1984830708 endingPage "529" @default.
• W1984830708 startingPage "527" @default.
• W1984830708 abstract "Leg ulcers are a well-recognized complication of beta thalassaemia intermedia, occurring frequently in patients with untreated or poorly controlled disease (Weatherall & Clegg, 1981). Poor tissue repair may be owing, at least in part, to the poor oxygen delivery to the peripheral tissues resulting from the high oxygen affinity of haemoglobin F, which may comprise more than 50% of the total haemoglobin in these patients. Increased knowledge of the biology of wound healing has led to a new understanding of the role of tissue growth factors in tissue repair (Ross et al, 1986; Kunimoto, 1999). Numerous trials of (recombinant) growth factor administration as adjunctive therapy to enhance the rate and quality of acute and chronic wound repair have been reported (Miller, 1999; Rees et al, 1999), but the outcomes have not been consistently reproducible in terms of wound healing. We postulated that a combination of platelet-derived growth factors, also called platelet-derived wound healing factors/formula (PDWHFs), could potentially promote better healing than either one used alone. We used PDWHFs to treat the chronic ulcer of one patient with beta thalassaemia intermedia. It was prepared from a pooled platelet concentrate of a matching blood group. The platelets were aliquoted into sterile single-dose vials under aseptic conditions and then placed in a freezer at a temperature of −25°C. At this temperature, the platelet membrane ruptures, leading to a release of the growth factors contained within the platelet alpha granules. The growth factor preparation was kept frozen until the time of use and thawed at room temperature prior to application. The patient was a 43-year-old woman with beta thalassaemia intermedia (β+IVS2-1A/β+IVS1-6C compound heterozygote) with a history of intractable ankle ulcers lasting nearly 20 years. Her general health was good and she had mild features of beta thalassaemia consistent with her underlying genotype. The patient was not on a regular transfusion programme nor had she been splenectomized. Her average haemoglobin was ≈9·0 g/dl, mean corpuscular volume (MCV) = 65 fl, HbA2 = 5·4% and HbF = 59%. At the onset of therapy, an ulcer was present on the left medial ankle area (Fig 1) that did not appear to be infected. Wound culture was negative. The surrounding skin exhibited blue-purple discoloration with scarring and scaling. There were no clinical signs of vascular disease on her legs with preserved distal pulses bilaterally. Doppler examination of the arteries and veins of her lower limbs and the ankle–brachial index were normal. Wound appearance before (left) and after (right) the treatment. Every evening, the patient applied a sterile gauze swab moistened with the thawed PDWHF, covered this with a paraffin-impregnated dressing (Jelonet) and bandaged the area. On alternate days, a dressing of saline-moistened gauze was applied in the morning. On d 1, baseline assessment of ulcer dimensions as well as wound culture was performed. At each visit, the ulcer area was assessed visually and measured by means of a graph acetate template (Opsite; Flexigrid). The extent of granulation tissue was assessed with a granulometer and swabs for culture were performed. The application of PDWHF resulted in a remarkable change in ulcer appearance. Within a few days, the border exhibited swelling and increasing perfusion. Granulation tissue developed in the ulcer base. No exudate or other signs of infection were observed. The surface area decreased from 10 cm2, measured on d 1 to 7·50 cm2 on d 18 and 3·95 cm2 on d 95. Complete healing was achieved by d 141 (Fig 1). The patient was treated with Ciprofloxacin orally for 14 d 6 weeks after therapy with PDWHF commenced, owing to a superficial wound infection associated with a decreased rate of healing. Three months later the condition remained stable. Further prospective studies on thalassaemic patients with leg ulcers seem justified to elucidate the wound healing potential of PDWHF compared with the recombinant platelet-derived growth factor (rPDGF)." @default.
• W1984830708 created "2016-06-24" @default.
• W1984830708 creator A5034412938 @default.
• W1984830708 creator A5034590965 @default.
• W1984830708 creator A5035418142 @default.
• W1984830708 creator A5054204086 @default.
• W1984830708 creator A5061354969 @default.
• W1984830708 creator A5065502905 @default.
• W1984830708 date "2001-02-01" @default.
• W1984830708 modified "2023-10-18" @default.
• W1984830708 title "Treatment of leg ulcers with platelet-derived wound healing factor (pdwhfs) in a patient with beta thalassaemia intermedia" @default.
• W1984830708 cites W2037783399 @default.
• W1984830708 cites W2047428308 @default.
• W1984830708 cites W2148371225 @default.
• W1984830708 doi "https://doi.org/10.1046/j.1365-2141.2001.02540-2.x" @default.
• W1984830708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11167859" @default.
• W1984830708 hasPublicationYear "2001" @default.
• W1984830708 type Work @default.
• W1984830708 sameAs 1984830708 @default.
• W1984830708 citedByCount "19" @default.
• W1984830708 countsByYear W19848307082013 @default.
• W1984830708 countsByYear W19848307082019 @default.
• W1984830708 countsByYear W19848307082021 @default.
• W1984830708 countsByYear W19848307082022 @default.
• W1984830708 countsByYear W19848307082023 @default.
• W1984830708 crossrefType "journal-article" @default.
• W1984830708 hasAuthorship W1984830708A5034412938 @default.
• W1984830708 hasAuthorship W1984830708A5034590965 @default.
• W1984830708 hasAuthorship W1984830708A5035418142 @default.
• W1984830708 hasAuthorship W1984830708A5054204086 @default.
• W1984830708 hasAuthorship W1984830708A5061354969 @default.
• W1984830708 hasAuthorship W1984830708A5065502905 @default.
• W1984830708 hasBestOaLocation W19848307081 @default.
• W1984830708 hasConcept C126322002 @default.
• W1984830708 hasConcept C141071460 @default.
• W1984830708 hasConcept C170493617 @default.
• W1984830708 hasConcept C181268634 @default.
• W1984830708 hasConcept C203014093 @default.
• W1984830708 hasConcept C2775960820 @default.
• W1984830708 hasConcept C2780269544 @default.
• W1984830708 hasConcept C71924100 @default.
• W1984830708 hasConcept C89560881 @default.
• W1984830708 hasConcept C90924648 @default.
• W1984830708 hasConceptScore W1984830708C126322002 @default.
• W1984830708 hasConceptScore W1984830708C141071460 @default.
• W1984830708 hasConceptScore W1984830708C170493617 @default.
• W1984830708 hasConceptScore W1984830708C181268634 @default.
• W1984830708 hasConceptScore W1984830708C203014093 @default.
• W1984830708 hasConceptScore W1984830708C2775960820 @default.
• W1984830708 hasConceptScore W1984830708C2780269544 @default.
• W1984830708 hasConceptScore W1984830708C71924100 @default.
• W1984830708 hasConceptScore W1984830708C89560881 @default.
• W1984830708 hasConceptScore W1984830708C90924648 @default.
• W1984830708 hasIssue "2" @default.
• W1984830708 hasLocation W19848307081 @default.
• W1984830708 hasLocation W19848307082 @default.
• W1984830708 hasOpenAccess W1984830708 @default.
• W1984830708 hasPrimaryLocation W19848307081 @default.
• W1984830708 hasRelatedWork W1490071071 @default.
• W1984830708 hasRelatedWork W1548246761 @default.
• W1984830708 hasRelatedWork W1551360064 @default.
• W1984830708 hasRelatedWork W1590785334 @default.
• W1984830708 hasRelatedWork W1983994607 @default.
• W1984830708 hasRelatedWork W1998274488 @default.
• W1984830708 hasRelatedWork W2282056048 @default.
• W1984830708 hasRelatedWork W2370333002 @default.
• W1984830708 hasRelatedWork W2385050991 @default.
• W1984830708 hasRelatedWork W4315432611 @default.
• W1984830708 hasVolume "112" @default.
• W1984830708 isParatext "false" @default.
• W1984830708 isRetracted "false" @default.
• W1984830708 magId "1984830708" @default.
• W1984830708 workType "article" @default.